Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer
2006 ◽
Vol 58
(6)
◽
pp. 742-748
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 606-606